As expected, in stage III and IV CRC patients, individuals with high DDX21 and high MCM5 expression had the poorest OS and DFS (Fig. 6J), rather than among all stage or stage I and II (Fig. S6G–J). Here, MCM5 is linked to colorectal carcinoma.